Loading…
Royalty Transparency Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
94pct
228d open
vs 5,649 other S bills in the 118th — cohort avg 33d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2024 · fourth_quarter · Science/Technology
NIST Framework on the exercise of march-in rights and how this could impact university tech transfer. Research Security provisions considered as part of FY2025 National Defense Authorization Act. S. 3664, Royal Transparency Act S. 4667, Research Review Act
Client expense: $160,000 · Firm income: Not reported
Placed on Senate Legislative Calendar under General Orders. Calendar No. 488.
Committee on Homeland Security and Governmental Affairs. Reported by Senator Peters with an amendment in the nature of a substitute. With written report No. 118-210.
Committee on Homeland Security and Governmental Affairs. Ordered to be reported with an amendment in the nature of a substitute favorably.
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Science/Technology
S. 3664 Royalty Transparency Act; S. 4667 Risky Research Review Act
Client expense: $160,000 · Firm income: Not reported
Government targets: SENATE
2024 · fourth_quarter · Science/Technology
NIST Framework on the exercise of march-in rights and how this could impact university tech transfer. Research Security provisions considered as part of FY2025 National Defense Authorization Act. S. 3664, Royal Transparency Act S. 4667, Research Review Act
Client expense: $140,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Medical/Disease Research/Clinical Labs
Issue: Educate Congress and the administration about the impact of regulatory burden on medical research. Issue: Support the role of academic medical centers in engaging with Advanced Research Projects Agency for Health (ARPA-H). Issue: Oppose inappropriate use of march-in authority. Issue: Educate Congress and the administration about opportunities to strengthen medical research supported by NIH. Issue: Provide input on proposed NIH optimization frameworks. Issue: Educate Congress and the administration about preparedness and lab safety for pathogens with pandemic potential. S.4667 - Risky Research Review Act Issue: Support prevention of unintended consequences from new restrictions on life sciences research. S. 3664 Royalty Transparency Act Issue: Support technical correction to ensure bill does not paralyze NIH peer review system. H.Res.1458 - Recognizing the contributions of medical research and observing "Medical Research Week" from September 16 through September 20, 2024. Issue: Educate Congress on unique role and benefits of supporting medical research and support for NIH.
Client expense: $632,324 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institute of Standards & Technology (NIST), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, White House Office